University of Louisville

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Louisville sits in the top decile of US sponsors by registered trial count (#149 of 15,742 sponsors by registered trial count).

217 total trials 46 currently recruiting 132 completed early-phase tilt top decile by trial count

University of Louisville: 217 sponsored US clinical trials, 46 recruiting.

University of Louisville sponsors 217 registered US clinical trials on ClinicalTrials.gov, 46 of them currently recruiting, and 132 completed. 26 of these trials are in Phase 3-4 (later-stage) and 42 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Spinal Cord Injuries, with 9 trials.

Top-decile sponsor footprint

University of Louisville ranks in the top decile of sponsors by registered trial count (#149 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 48/100

132 of 158 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (83.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

217 total, page 3 of 5

COMPLETED NA

Imaginal Exposure II Study: In-Vivo

NCT03934697

COMPLETED NA

Video-Laryngoscope Alone or With Bronchoscope for Predicted Difficult Intubation

NCT03080896

COMPLETED Phase 4

Vaginal and Urinary Microbiome Trial

NCT02869165

COMPLETED NA

Online Imaginal Exposure

NCT03712748

COMPLETED NA

Ridge Preservation Comparing the Healing With or Without a Barrier Membrane

NCT02798887

COMPLETED NA

Stepping Up 4 Your Child

NCT02843113

COMPLETED NA

VITOM Study: A Randomized, Controlled Trial.

NCT03120689

COMPLETED Phase 2

Carnosine for Peripheral Arterial Disease

NCT04870229

COMPLETED NA

Computer-assisted Cognitive-Behavior Therapy for Depression in Primary Care

NCT02700009

COMPLETED NA

Percutaneous Nerve Evaluation With Fluoroscopy Versus Without

NCT02677753

COMPLETED NA

Using Media to Shift Social Norms of Violence Among Youth

NCT02706145

COMPLETED NA

The Effect of Platform-Matching Versus Platform-Switching Dental Implants on Peri-implant Hard and Soft Tissue Healing

NCT02536716

COMPLETED NA

PAV vs Assist Control After Failed SBT

NCT02773433

COMPLETED NA

Cohort 2 Efficacy of Nasopharyngeal Ventilation With Endotracheal Tube for Surgery

NCT02018146

TERMINATED NA

Evaluation of a Disposable Flexible Bronchoscope, aScope IV

NCT02255838

TERMINATED Phase 1

Phase I/II: Decitabine/Vaccine Therapy in Relapsed/Refractory Pediatric High Grade Gliomas/Medulloblastomas/CNS PNETs

NCT02332889

COMPLETED NA

Flunisolide HFA in Children With Small Airway Disease

NCT02404103

COMPLETED Early Phase 1

Outcomes of Renal Function in Hepatorenal Syndrome (HRS) Determined By Comparison of Target Mean Arterial Pressure (MAP) of 65 - 70 Mmhg Versus ≥ 85 Mmhg

NCT02789150

COMPLETED NA

The Effect of Protandim Supplementation on Oxidative Damage and Athletic Performance

NCT02172625

COMPLETED Phase 2

Effects of Folfirinox and Stereotactic Body Radiation Therapy for Advanced Pancreatic Cancer

NCT02128100

COMPLETED NA

Recovery of Bladder and Sexual Function After Spinal Cord Injury

NCT03036527

TERMINATED NA

Preoperative Nutrition With Immune Enhancing Nutritional Supplement (Immunomodulation)

NCT02838966

TERMINATED NA

Comparison of Outcomes During MRI Sedation With Midazolam-dexmedetomidine Versus Ketamine-dexmedetomidine

NCT02129426

COMPLETED NA

Recovery of Cardiovascular Function With Epidural Stimulation After Human Spinal Cord Injury

NCT02037620

COMPLETED Phase 4

Ridge Preservation Comparing a Polylactic Acid Membrane vs. an Acellular Dermal Matrix Membrane

NCT02152215

COMPLETED NA

Articulating Enseal Versus Ligasure Energy Devices

NCT02163538

COMPLETED NA

The Clinical Effect of Implant Placement With a Simultaneous Soft Tissue Allograft

NCT02139748

COMPLETED

A Study to Assess Benign Joint Hypermobility Syndrome in Children With a History of Wheezing or Asthma

NCT02163096

COMPLETED NA

Diagnostic Value of Passive Leg Raise Induced Changes in Carotid Artery Flow Time to Predict Fluid Responsiveness in Critically Ill Patients

NCT02789124

COMPLETED Phase 4

Ridge Augmentation Comparing a Block Allograft to a Demineralized Bone Matrix Allograft.

NCT02127112

COMPLETED

Internal Jugular Ultrasound Measures During Respiration in Children

NCT02004938

COMPLETED NA

Ridge Preservation Comparing 2 Membranes

NCT01905280

COMPLETED NA

Root Coverage Comparing Suturing Techniques

NCT01901822

COMPLETED NA

Ridge Augmentation Without Primary Closure

NCT01901783

COMPLETED Phase 2

Skin Rash Study Before Chemotherapy in Colorectal & Head and Neck Cancer Patients

NCT01874860

COMPLETED NA

Social Media, Teen Moms and PPD

NCT01967394

COMPLETED Phase 4

Intramuscular Epinephrine as an Adjunctive Treatment for Severe Pediatric Asthma Exacerbation

NCT01705964

COMPLETED Phase 1

Study To Examine Toxicity Of Allogeneic Stem Cell Transplantation For Relapsed Or Therapy Refractory Ewings Sarcoma

NCT02472392

COMPLETED

Prospective Observational Study of Erythropoietin-Iron Interaction in Anemia of Renal Disease

NCT01719146

COMPLETED

A Micro/Nano Device for Exhaled Breath Analysis

NCT02123030

COMPLETED NA

Implant Placement and Simultaneous Soft Tissue Grafting With Single or Double Layers of Acellular Dermal Matrix

NCT01902056

COMPLETED NA

Ridge Preservation Comparing a PTFE Nonresorbable Membrane to a Collagen Membrane

NCT01900964

COMPLETED Phase 1

Edible Plant Exosome Ability to Prevent Oral Mucositis Associated With Chemoradiation Treatment of Head and Neck Cancer

NCT01668849

TERMINATED NA

Overcoming Chemotherapy Resistance In Refractory Multiple Myeloma With Simvastatin and Zoledronic Acid

NCT01772719

COMPLETED NA

Adherence Rate of Monthly Bubble Package Among Patients Prescribed Adjuvant Endocrine Therapy in Breast Cancer Survivors

NCT01694225

COMPLETED Phase 4

Comparison of Wound Bed Establishment in Facial Burns

NCT01668030

COMPLETED NA

Tobacco Dependence Treatment Education for Dental Students

NCT01522924

COMPLETED Phase 1

A Phase I/II Open-Label Study of Ipilimumab and GM-CSF Administered to Unresectable Stage IIIC and Stage IV Melanoma Patients

NCT02009397

TERMINATED NA

Phase II Trial of Stereotactic Radiation Therapy (SRT) Versus SRT Plus Vertebral Augmentation Procedure (VAP) for Vertebral Metastasis

NCT01527292

COMPLETED NA

Direct Peritoneal Resuscitation Effects in the Damage Control Patient

NCT01771055

← Previous Page 3 of 5 Next →

What is open in the University of Louisville pipeline

46 recruiting of 217 indexed (21% open); 132 completed (61%).

Phase mix: 26 late (III/IV) vs 42 early (I/II) (early-phase heavy).

Top condition: Spinal Cord Injuries (9 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Louisville: open-pipeline peers nationwide

Peers matched on 217 registered trials and 21% open enrollment, not the therapeutic-area sidebar.

University of Louisville sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0200400600 0%5%10%15%20%25% Total trials Recruiting share University of LouisvilleFlorida State UniversityPenn State UniversityNational Eye Institute (NEI)Otsuka Pharmaceutical Development & CommercializationOhio State UniversityMedical College of WisconsinNova Southeastern UniversityColorado State University
University of Louisville sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Louisville sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 217 trials (± recruiting share)

Sponsors near 21% open enrollment (± trial volume)

What to do with this University of Louisville page

217 registered trials is a research-attention snapshot, not an endorsement of University of Louisville or any single study.

  • 46 of University of Louisville's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Spinal Cord Injuries is the condition University of Louisville studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Spinal Cord Injuries trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Louisville pipeline card: 217 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.